LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
May 9, 2018
Translation in Brief
The fate of NK cells
Differentiation states of CAR-transfected NK cells influence anticancer function
Read More
BioCentury
|
Mar 9, 2018
Company News
BMS, Innate say no plans to table lirilumab just yet
Read More
BioCentury
|
Dec 1, 2017
Clinical News
Innate sees no development path for lirilumab combo therapies
Read More
BioCentury
|
Apr 7, 2017
Finance
Combo quest
Why NantKwest led Viracta’s B round
Read More
BioCentury
|
Feb 10, 2017
Clinical News
Lirilumab: Ph II EffiKIR data
Read More
BioCentury
|
Feb 6, 2017
Clinical News
Innate's lirilumab fails Phase II AML trial
Read More
BioCentury
|
Jan 12, 2017
Company News
Innate Pharma, Bristol-Myers deal
Read More
BioCentury
|
Nov 11, 2016
Clinical News
Lirilumab: Ph I/II CA223-001 data
Read More
BioCentury
|
Nov 9, 2016
Clinical News
Lirilumab combo shows early promise in SCCHN
Read More
BioCentury
|
Nov 5, 2016
Finance
Vive la biotech
Why investors are paying more attention to French biotech
Read More
Items per page:
10
1 - 10 of 35